Dataset Information
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
Ontology highlight
ABSTRACT:
SUBMITTER: Samimagham HR
PROVIDER: S-EPMC8258474 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
Publications
Evaluation of the efficacy and safety of recombinant erythropoietin on the improvement of hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
Trials 20210706 1
<h4>Objectives</h4>To evaluate the effect of recombinant erythropoietin on hospitalised COVID-19 patients.<h4>Trial design</h4>Concealed, randomized, single-blinded, phase 2 controlled clinical trial with two arm parallel-group design of 20 patients allocated with 1:1 ratio and using the placebo in the control group.<h4>Participants</h4>This study will be performed at Shahid Mohammadi Hospital in Bandar Abbas, Hormozgan in Iran. All positive (PCR confirmed) COVID-19 patients ≤65 years old who ha ...[more]